Equillium Inc.(EQ)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EQ Equillium Inc.

交易中 12-15 14:18:40 EST

1.21

-0.07

-5.47%

最高1.34	最低1.17	成交量33.17万
今开1.34	昨收1.28	日振幅13.27%
总市值7,368万	流通市值5,266万	总股本6,089万
成交额41.02万	换手率0.76%	流通股本4,352万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"EQ","market":"US","secType":"STK","nameCN":"Equillium Inc.","latestPrice":1.21,"timestamp":1765826309250,"preClose":1.28,"halted":0,"volume":331700,"delay":0,"floatShares":43524300,"shares":60893283,"eps":-0.572223,"marketStatus":"交易中","change":-0.07,"latestTime":"12-15 14:18:40 EST","open":1.34,"high":1.34,"low":1.1702,"amount":410229.70964,"amplitude":0.132656,"askPrice":1.22,"askSize":1388,"bidPrice":1.2,"bidSize":764,"shortable":3,"etf":0,"ttmEps":-0.572223,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765832400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1539316800000,"exchange":"NASDAQ","adjPreClose":1.28,"preHourTrading":{"tag":"盘前","latestPrice":1.33,"preClose":1.28,"latestTime":"09:29 EST","volume":6236,"amount":8083.5590516,"timestamp":1765808999999},"postHourTrading":{"tag":"盘后","latestPrice":1.28,"preClose":1.28,"latestTime":"19:59 EST","volume":964,"amount":1220.8181,"timestamp":1765587547267},"volumeRatio":0.610842,"impliedVol":2.5532,"impliedVolPercentile":0.828},"requestUrl":"/m/hq/s/EQ","defaultTab":"news","newsList":[{"id":"2588018744","title":"七座版奔驰GLC EQ首曝：车身加长 迎合中国市场需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2588018744","media":"IT之家","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588018744?lang=zh_cn&edition=full","pubTime":"2025-12-03 14:11","pubTimestamp":1764742281,"startTime":"0","endTime":"0","summary":"IT之家 12 月 3 日消息，汽车媒体 CarScoops 昨日 发布博文，报道称在慕尼黑车展发布 GLC EQ 五座版后，梅赛德斯-奔驰斯正在测试一款体型更大、采用三排七座的变体车型。外观方面，七座版 GLC EQ 延续了标准版的设计语言，但在 B 柱之后进行了显著调整。该媒体认为，这款三排座纯电跨界车主要是为了迎合中国市场对大空间、多座位车型的偏好而设计。IT之家附上相关图片如下：","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8omctTD8nZW","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["CQQQ","BK4568","CWEB","EQ","MCHI","DRAG","ASHS","ASHR","BK4588","FXI","KWEB","YINN","BK4614","BK4585","BK4139","CHAU"],"gpt_icon":1},{"id":"2580789280","title":"Equillium, Inc.盘中异动 股价大涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580789280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580789280?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:59","pubTimestamp":1762181985,"startTime":"0","endTime":"0","summary":"北京时间2025年11月03日22时59分，Equillium, Inc.股票出现波动，股价急速上涨5.32%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103225946a6de31ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103225946a6de31ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","EQ"],"gpt_icon":0},{"id":"2567186498","title":"奔驰确认将逐步弃用“EQ”品牌，未来转向“Electric”命名","url":"https://stock-news.laohu8.com/highlight/detail?id=2567186498","media":"IT之家","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567186498?lang=zh_cn&edition=full","pubTime":"2025-09-13 12:18","pubTimestamp":1757737090,"startTime":"0","endTime":"0","summary":"IT之家 9 月 13 日消息，梅赛德斯-奔驰长期以来在电动车型上使用 EQ 子品牌，并推出了 EQS、EQE 轿车及其 SUV 版本。奔驰首席技术官 Markus Schfer 本周二在接受《新闻周刊》采访时确认，公司将逐步放弃 EQ 标识，转而使用“Electric”作为新命名。IT之家提醒，“Electric”对应的中文名可能类似于纯电 CLA、纯电 GLC 这种带有“纯电”的词缀。Schfer 表示：我们正在转向使用 Electric 这一名称。奔驰并不会马上切换命名。奔驰官网的未来车型页面上仍显示 2027 款 GLC with EQ Technology。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8mc2kBWeQTg","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK4139","BK4568","EQ"],"gpt_icon":0},{"id":"1138387172","title":"Equillium Inc申请发行最多5263万股普通股 现有股东出售 - SEC备案文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1138387172","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138387172?lang=zh_cn&edition=full","pubTime":"2025-09-10 05:03","pubTimestamp":1757451784,"startTime":"0","endTime":"0","summary":"Equillium Inc根据美国证监会备案文件申请发行最多5263万股普通股，由现有股东进行出售。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","EQ","BK4139"],"gpt_icon":0},{"id":"2564305542","title":"Equillium, Inc.盘中异动 早盘急速跳水5.35%报1.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2564305542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564305542?lang=zh_cn&edition=full","pubTime":"2025-09-04 23:05","pubTimestamp":1756998332,"startTime":"0","endTime":"0","summary":"北京时间2025年09月04日23时05分，Equillium, Inc.股票出现异动，股价快速下跌5.35%。截至发稿，该股报1.77美元/股，成交量13.7785万股，换手率0.39%，振幅4.81%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904230532a70fe70d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904230532a70fe70d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EQ","BK4568","BK4139"],"gpt_icon":0},{"id":"1122602412","title":"Equillium Inc根据纳斯达克上市规则5635(C)(4)报告诱导授予","url":"https://stock-news.laohu8.com/highlight/detail?id=1122602412","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122602412?lang=zh_cn&edition=full","pubTime":"2025-09-04 06:01","pubTimestamp":1756936864,"startTime":"0","endTime":"0","summary":"Equillium Inc宣布根据纳斯达克上市规则5635(C)(4)进行诱导授予。该规则要求上市公司对特定类型的员工激励计划进行适当披露和报告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","EQ","BK4139"],"gpt_icon":0},{"id":"2558666680","title":"Equillium公司（股票代码：EQ）因股价波动暂停交易。","url":"https://stock-news.laohu8.com/highlight/detail?id=2558666680","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558666680?lang=zh_cn&edition=full","pubTime":"2025-08-11 22:13","pubTimestamp":1754921634,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["EQ","BK4568","BK4139"],"gpt_icon":0},{"id":"2558666699","title":"Equillium, Inc.盘中异动 股价大涨122.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558666699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558666699?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:30","pubTimestamp":1754919004,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时30分，Equillium, Inc.股票出现波动，股价快速拉升122.13%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Zymeworks Inc.、Zevra Therapeutics, Inc.、Zura Bio Limited涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.较为活跃，换手率分别为1648.81%、183.35%、73.33%，振幅较大的相关个股有Zymeworks Inc.、Zevra Therapeutics, Inc.、Zura Bio Limited，振幅分别为0.00%、0.00%、0.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811213005a6dfb74c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811213005a6dfb74c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","EQ"],"gpt_icon":0},{"id":"2558557949","title":"Equillium, Inc.盘中异动 急速下跌5.97%报0.520美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558557949","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558557949?lang=zh_cn&edition=full","pubTime":"2025-08-09 01:44","pubTimestamp":1754675083,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日01时44分，Equillium, Inc.股票出现异动，股价大幅跳水5.97%。截至发稿，该股报0.520美元/股，成交量17.9135万股，换手率0.50%，振幅9.04%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为1.10%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809014443a47daec1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809014443a47daec1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","EQ"],"gpt_icon":0},{"id":"2557678555","title":"Equillium, Inc.盘中异动 早盘股价大跌5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557678555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557678555?lang=zh_cn&edition=full","pubTime":"2025-08-07 23:14","pubTimestamp":1754579665,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日23时14分，Equillium, Inc.股票出现波动，股价大幅下跌5.57%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807231425a6d91feb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807231425a6d91feb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","EQ"],"gpt_icon":0},{"id":"2557308234","title":"Equillium, Inc.盘中异动 股价大跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557308234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557308234?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:36","pubTimestamp":1754487367,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日21时36分，Equillium, Inc.股票出现波动，股价急速下挫5.52%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080621360797378a20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080621360797378a20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EQ","BK4568"],"gpt_icon":0},{"id":"2556812008","title":"Equillium, Inc.盘中异动 早盘急速上涨6.88%报0.418美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556812008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556812008?lang=zh_cn&edition=full","pubTime":"2025-08-01 23:06","pubTimestamp":1754060772,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日23时06分，Equillium, Inc.股票出现异动，股价大幅上涨6.88%。截至发稿，该股报0.418美元/股，成交量9.898万股，换手率0.28%，振幅5.40%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。该公司的其他临床阶段和临床前阶段候选药物包括EQ101和EQ302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080123061294c93174&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080123061294c93174&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","EQ"],"gpt_icon":0},{"id":"2555704724","title":"Equillium, Inc.盘中异动 早盘股价大涨5.26%报0.420美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555704724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555704724?lang=zh_cn&edition=full","pubTime":"2025-07-30 21:53","pubTimestamp":1753883622,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日21时53分，Equillium, Inc.股票出现异动，股价急速拉升5.26%。截至发稿，该股报0.420美元/股，成交量3.1605万股，换手率0.09%，振幅5.76%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730215342a6c9dc98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730215342a6c9dc98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EQ","BK4568","BK4139"],"gpt_icon":0},{"id":"2555044891","title":"取代 EQC，梅赛德斯-奔驰发布纯电 SUV 新车 GLC EQ 预告","url":"https://stock-news.laohu8.com/highlight/detail?id=2555044891","media":"市场资讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555044891?lang=zh_cn&edition=full","pubTime":"2025-07-30 20:18","pubTimestamp":1753877880,"startTime":"0","endTime":"0","summary":"IT之家 7 月 30 日消息，据外媒 Carscoops 今晚报道，梅赛德斯-奔驰全新打造的纯电动 GLC 车型即将正式亮相，新车将登陆 9 月的 IAA Mobility 展会。GLC EV 预计将延续燃油版 GLC 的整体体型，并在外观设计上焕然一新。据悉，首发版本为 GLC 400 4Matic EQ Technology。除了电动 GLC ，奔驰还将在慕尼黑展示 MB.Drive Assist Pro 半自动驾驶系统，并提供搭载该系统的 CLA 车型试乘体验。此外，极具视觉冲击力的 Concept AMG GT XX 概念车也将与 GLC EV 一同登场。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/t/2025-07-30/doc-infihfyq8199761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["EQC","BK4194","BK4568","BK4223","EQ","BK4139"],"gpt_icon":0},{"id":"2554777373","title":"Equillium, Inc.股价上涨16.71% 市值涨64.51万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554777373","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554777373?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:36","pubTimestamp":1753709791,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时36分，Equillium, Inc.股票出现异动，股价急速拉升16.71%。截至发稿，该股报0.470美元/股，成交量4.41万股，换手率0.12%，振幅5.46%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072821363194bf70af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072821363194bf70af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EQ","BK4568","BK4139"],"gpt_icon":0},{"id":"2551126395","title":"Equillium, Inc.盘中异动 早盘大幅上涨5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551126395","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551126395?lang=zh_cn&edition=full","pubTime":"2025-07-16 22:01","pubTimestamp":1752674517,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日22时01分，Equillium, Inc.股票出现异动，股价急速上涨5.51%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162201579544f1e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162201579544f1e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EQ","BK4568","BK4139"],"gpt_icon":0},{"id":"2551182840","title":"Equillium, Inc.盘中异动 早盘急速下跌5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551182840","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551182840?lang=zh_cn&edition=full","pubTime":"2025-07-14 22:05","pubTimestamp":1752501907,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日22时05分，Equillium, Inc.股票出现波动，股价大幅下挫5.40%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714220507a44a2d00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714220507a44a2d00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","EQ","BK4139"],"gpt_icon":0},{"id":"2550245959","title":"Equillium, Inc.盘中异动 大幅拉升6.26%报0.370美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550245959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550245959?lang=zh_cn&edition=full","pubTime":"2025-07-11 21:38","pubTimestamp":1752241137,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日21时38分，Equillium, Inc.股票出现异动，股价大幅拉升6.26%。截至发稿，该股报0.370美元/股，成交量9.0443万股，换手率0.25%，振幅3.48%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071121385897a2610e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071121385897a2610e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","EQ","BK4139"],"gpt_icon":0},{"id":"2550655700","title":"Equillium, Inc.盘中异动 股价大涨5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550655700","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550655700?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:12","pubTimestamp":1752070376,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时12分，Equillium, Inc.股票出现异动，股价大幅上涨5.77%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为1.31%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709221256953c3e7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709221256953c3e7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","EQ","BK4139"],"gpt_icon":0},{"id":"2549557730","title":"Equillium, Inc.盘中异动 下午盘股价大涨5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549557730","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549557730?lang=zh_cn&edition=full","pubTime":"2025-07-08 03:26","pubTimestamp":1751916394,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日03时26分，Equillium, Inc.股票出现异动，股价快速上涨5.55%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708032634979d5f18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708032634979d5f18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","EQ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.equilliumbio.com","stockEarnings":[{"period":"1week","weight":0.5016},{"period":"1month","weight":0.3853},{"period":"3month","weight":-0.3155},{"period":"6month","weight":2.6888},{"period":"1year","weight":0.8241},{"period":"ytd","weight":0.7108}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Equillium, Inc.于2017年3月16日在特拉华州注册成立，该公司前身为Attenuate Biopharmaceuticals，Inc.。该公司是一家临床阶段的生物技术公司，利用对免疫生物学的深刻理解来开发新的疗法，以治疗具有高度未满足医疗需求的严重自身免疫和炎症，或免疫炎症疾病。公司战略专注于推进候选产品的临床开发，包括潜在地寻求额外的适应症和获得新的候选产品和平台以扩大管道。该公司打算独立或通过合作伙伴关系将候选产品商业化，或通过战略交易将公司管道货币化。","yearOnYearQuotes":[{"month":1,"riseRate":0.857143,"avgChangeRate":0.074209},{"month":2,"riseRate":0.571429,"avgChangeRate":0.328463},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.190483},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.137456},{"month":5,"riseRate":0.714286,"avgChangeRate":0.036577},{"month":6,"riseRate":0.142857,"avgChangeRate":-0.151956},{"month":7,"riseRate":0.571429,"avgChangeRate":0.329165},{"month":8,"riseRate":0.714286,"avgChangeRate":0.556288},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.085401},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.070521},{"month":11,"riseRate":0.25,"avgChangeRate":-0.089283},{"month":12,"riseRate":0.5,"avgChangeRate":-0.051933}],"exchange":"NASDAQ","name":"Equillium Inc.","nameEN":"Equillium Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Equillium Inc.(EQ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Equillium Inc.(EQ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Equillium Inc.,EQ,Equillium Inc.股票,Equillium Inc.股票老虎,Equillium Inc.股票老虎国际,Equillium Inc.行情,Equillium Inc.股票行情,Equillium Inc.股价,Equillium Inc.股市,Equillium Inc.股票价格,Equillium Inc.股票交易,Equillium Inc.股票购买,Equillium Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Equillium Inc.(EQ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Equillium Inc.(EQ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}